Payton Fennell, DO
Sports Medicine · Charlotte, NCNPI 1306906086
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (43.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Arthrex at 48.9% of the total. Reporting peaked in 2019 at $3,975 and has fallen 99.7% since, to $12 in 2022.
Across 73 payments — averaging $62.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Peerless Surgical Inc.$2K
- Johnson & Johnson$137
- GSK$94
- AstraZeneca$85
- Lilly USA, LLC$84
- plus $430 from 14 others
What the payments were for
- Travel & lodging$1,47632%
- Food & beverage$1,13925%
- Education$1,97743%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 8 | $2,247 |
| Peerless Surgical Inc. | 5 | $1,515 |
| Johnson & Johnson | 11 | $137 |
| GSK | 6 | $94 |
| AstraZeneca | 7 | $85 |
| Lilly USA, LLC | 6 | $84 |
| Novo Nordisk | 7 | $83 |
| Ironshore Pharmaceuticals Inc. | 3 | $50 |
| Teva Pharmaceuticals USA, Inc. | 4 | $49 |
| Amarin Pharma, Inc. | 3 | $39 |
| Neos Therapeutics, LP | 2 | $31 |
| Pacira Therapeutics, Inc. | 1 | $29 |
| Pfizer | 2 | $27 |
| CSL Behring | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Bausch Health US, LLC | 1 | $14 |
| Tris Pharma Inc | 1 | $14 |
| Ironwood Pharmaceuticals, Inc | 1 | $13 |
| Smith+Nephew | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BIOLOGICS CONSUMABLES ACCESSORIES ANGEL PRP$125
How this compares
$4,592 in reported general payments places this provider in the 70th percentile of 158 sports medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tizanidine Hcl | 51 | $192 |
| Tramadol Hcl | 45 | $190 |
| Celecoxib | 17 | $174 |
| Meloxicam | 74 | $140 |
| Diclofenac Sodium | 17 | $121 |
| Prednisone | 68 | $101 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Charlotte
- Fletcher PreussCharlotte$53K
- Benjamin RothrauffCharlotte$37K
- Aaron EllisonCharlotte$14K
- David PriceCharlotte$8K
- Jason TuckerCharlotte$5K
- Eric WarrenCharlotte$2K
- Brian WatermanWinston Salem$360K
- Allston StubbsWinston Salem$184K
- Robert BoykinAsheville$126K
- Tally EddingsAsheville$109K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.